NCT02268760View on ClinicalTrials.gov

Safety, Tolerance, and Pharmacokinetics of BILN 2061 ZW in Healthy Male Subjects, Combined With Preliminary Evaluation of Food Effect

PHASE1CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

September 30, 2001

Conditions
Healthy
Interventions
DRUG

BILN 2061 ZW single rising doses

DRUG

Placebo

DRUG

BILN 2061 ZW fixed dose

OTHER

Standardized breakfast

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY